Medindia

X

North America Porcine Vaccine Market to US$926.2 Million by 2024: High Cost of Maintaining Cold Chains to Hinder Growth

Tuesday, November 29, 2016 Research News J E 4
Advertisement

ALBANY, New York, November 29, 2016 /PRNewswire/ --

The North America Porcine Vaccines Market for features an essentially fragmented marketplace, with the presence of a large number of small and large players. The market, however, is dominated by few; the top four players, namely Merial Animal Health, Zoetis, Inc., Elanco Animal Health, and Merck Animal Health, for instance, collectively held nearly 74% of the overall market in 2015, observes a recent report by Transparency Market Research. 

Factors such as diverse product portfolios, extensive geographical presence, and perceptive acquisitions, as well as intensive research and development and the timely introduction of new vaccines have kept these players ahead of the intense competition. Instances are: The launch of two new swine vaccines by Boehringer Ingelheim Animal Health in 2015: Ingelvac and ReproCyc. The vaccines have been launched to fight against the porcine reproductive and respiratory syndrome (PRRS) virus. Zoetis' November 2016 launch of Fostera PCV Metastim, a monovalent killed vaccine that protects against porcine circovirus associated diseases (PCVAD). 

Transparency Market Research estimates that the North America Porcine Vaccine market will exhibit a 5.3% CAGR from 2016 to 2024 and rise from a valuation of US$540.9 mn in 2015 to US$926.2 mn by 2024. 

Download PDF Brochure of Research Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=16976

In terms of disease indication, the diarrhea vaccines segment dominates the North America porcine vaccine market and is expected to account for nearly 55% of the market by 2016. The segment is expected to exhibit a healthy 7.3% CAGR over the period between 2016 and 2024 and gain a much larger, nearly 60% of the overall market, by 2024. In terms of geography, the North America porcine vaccines market is dominated by the U.S., which accounted for over 63% of the overall market in 2015 and is expected to remain the dominant market over the forecast period as well. 

Rising Consumption of Meat and Gelatin to Remain Key to Market Growth 

The market for porcine vaccines in North America is chiefly driven due to factors such as the rising prevalence of swine diseases and the continuously increasing demand for meat and gelatin in the global market. Owing to globalization and rapid climate changes, the rate of outbreak of various animal diseases, some of which are also transmissible to humans, has picked up pace. Swine being a highly popular source of meat, consumed in increasingly high volumes worldwide, the impact of zoonotic diseases emanating from this class of livestock can be highly devastating for livestock as well as human lives. 

North America is the third largest consumer of pork globally. As a result, concerns regarding the spread of zoonotic diseases from swine and related products are well-founded and are rising. These concerns will be key to the increased focus on the health and wellness of swines from livestock farmers and will drive the overall North America porcine vaccine market. 

High and Rising Cost of Storing Vaccines to Obstruct Growth 

Appropriate storage and handling of vaccines play a key role in ensuring high success rate of a vaccine against any vaccine-preventable disease. The need to strictly adhere to proper storage and handling procedures, lest incur losses worth thousands of dollars in revaccination and wasted vaccine, requires maintaining proper cold chains. 

Such cold chains are required to be maintained across all nodes of the supply chain, starting from the manufacturers to the healthcare providers. The high costs of maintaining these storage and handling conditions, which continue to rise with every passing day, are one of the key challenges faced by the North America porcine vaccine market and are expected to restrain the market's growth to a certain extent over the forecast period. 

Get Discounts on Report Purchase: http://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=16976

This review of the market is based on a recent market research report published by TMR, titled "Porcine Vaccine Market - North America Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024." 

For the study, the North America porcine vaccine market is segmented into: 

North America Porcine Vaccine Market, by Disease Indication 

  • Diarrhoea
  • Swine Influenza
  • Arthritis
  • Bordatella Rhinitis
  • Porcine Reproductive and Respiratory Virus (PRRSV)
  • Porcine Circovirus Associated Disease (PCVAD)
  • Others

North America Porcine Vaccine Market, by Technology 

  • Nuclear Reactors
  • Cyclotrons

North America Porcine Vaccine Market, by End-user 

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Others

North America Porcine Vaccine Market, by Region 

  • U.S.
  • Canada

Browse Related Research Report: 

Nuclear Medicine Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023: http://www.transparencymarketresearch.com/nuclear-medicine-market.html

Veterinary Vaccines Market (Animal Type - Companion Animals (Equine, Canine, and Feline) and Livestock Animals (Bovine, Ovine, Porcine, and Poultry); Technology Type - Inactivated Vaccines, Live Attenuated Vaccines, Conjugate Vaccines, and Toxoid Vaccines) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024: http://www.transparencymarketresearch.com/veterinary-vaccines-market.html

About Us: 

Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us: Transparency Market Research 90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Blog: http://www.tmrblog.com/

SOURCE Transparency Market Research

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Beyond the Failed Beta Amyloid Hypothesis -- Alzhe...
S
Asia-Pacific Anti-hypertensive Therapeutics Market...